Brief: Fusion Pharmaceuticals Strengthens Actinium Supply With Onsite Isotope Production Through Expanded Bwxt Medical Collaboration
16/11/2023 11:57
Nov 16 (Reuters) - BWX Technologies Inc BWXT.N :
* FUSION PHARMACEUTICALS STRENGTHENS ACTINIUM SUPPLY WITH
ONSITE
ISOTOPE PRODUCTION THROUGH EXPANDED BWXT MEDICAL COLLABORATION
* FUSION PHARMACEUTICALS INC: COLLABORATION ENABLES FUSION
TO
PRODUCE HIGH PURITY ACTINIUM-225 AT COMPANY'S GMP MANUFACTURING
FACILITY
Source text for Eikon: ID:nPn6GwRVra
Further company coverage: BWXT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary